ABC
AVNS

Associated Banc-Corp’s Avanos Medical AVNS Stock Holding History

Associated Banc-Corp’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,718
Closed -$306K – 320
2024
Q3 		$306K Sell
12,718
-10,707
-46% -$245K 0.01% 283
2024
Q2 		$467K Sell
23,425
-3,226
-12% -$62.8K 0.01% 242
2024
Q1 		$531K Sell
26,651
-1,253
-4% -$24.2K 0.02% 231
2023
Q4 		$626K Buy
27,904
+14,894
+114% +$307K 0.02% 226
2023
Q3 		$263K Sell
13,010
-34
-0.3% -$771 0.01% 269
2023
Q2 		$333K Sell
13,044
-873
-6% -$23K 0.01% 258
2023
Q1 		$414K Sell
13,917
-908
-6% -$26.4K 0.02% 245
2022
Q4 		$401K Hold
14,825
– – 0.02% 245
2022
Q3 		$323K Hold
14,825
– – 0.01% 253
2022
Q2 		$405K Hold
14,825
– – 0.02% 240
2022
Q1 		$497K Sell
14,825
-39
-0.3% -$1.26K 0.02% 238
2021
Q4 		$515K Sell
14,864
-2,174
-13% -$70.3K 0.02% 233
2021
Q3 		$532K Sell
17,038
-650
-4% -$22.1K 0.02% 226
2021
Q2 		$643K Sell
17,688
-23,916
-57% -$989K 0.03% 221
2021
Q1 		$1.12M Buy
41,604
+22,177
+114% +$1.04M 0.07% 158
2020
Q4 		$892K Sell
19,427
-10,186
-34% -$424K 0.03% 222
2020
Q3 		$984K Sell
29,613
-4,728
-14% -$151K 0.04% 206
2020
Q2 		$1.01M Sell
34,341
-7,284
-17% -$211K 0.05% 202
2020
Q1 		$1.12M Sell
41,625
-5,294
-11% -$158K 0.06% 187
2019
Q4 		$1.58M Sell
46,919
-302
-0.6% -$10.9K 0.08% 158
2019
Q3 		$1.77M Sell
47,221
-1,955
-4% -$74.6K 0.1% 151
2019
Q2 		$2.14M Sell
49,176
-41
-0.1% -$1.75K 0.12% 141
2019
Q1 		$2.1M Sell
49,217
-232
-0.5% -$10.4K 0.12% 141
2018
Q4 		$2.21M Sell
49,449
-3,001
-6% -$157K 0.14% 134
2018
Q3 		$3.59M Sell
52,450
-2,504
-5% -$161K 0.2% 118
2018
Q2 		$3.15M Sell
54,954
-65,485
-54% -$3.46M 0.18% 121
2018
Q1 		$5.55M Sell
120,439
-668
-0.6% -$31.7K 0.32% 86
2017
Q4 		$5.59M Sell
121,107
-16,676
-12% -$766K 0.3% 83
2017
Q3 		$6.21M Buy
137,783
+59
+0% +$2.52K 0.34% 74
2017
Q2 		$5.41M Sell
137,724
-209
-0.2% -$7.9K 0.31% 76
2017
Q1 		$5.25M Sell
137,933
-403
-0.3% -$15.7K 0.31% 82
2016
Q4 		$5.12M Buy
138,336
+2,463
+2% +$88K 0.32% 81
2016
Q3 		$4.71M Sell
135,873
-2,016
-1% -$70.6K 0.3% 86
2016
Q2 		$4.48M Sell
137,889
-12,811
-9% -$392K 0.29% 88
2016
Q1 		$4.33M Sell
150,700
-3,295
-2% -$87.8K 0.28% 87
2015
Q4 		$5.14M Sell
153,995
-913
-0.6% -$28.4K 0.34% 81
2015
Q3 		$4.41M Sell
154,908
-70
-0% -$2.44K 0.31% 85
2015
Q2 		$6.28M Buy
154,978
+6,885
+5% +$309K 0.4% 72
2015
Q1 		$7.29M Buy
148,093
+6,696
+5% +$310K 0.46% 68
2014
Q4 		$6.43M Buy
+141,397
New +$5.56M 0.41% 72

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Associated Banc-Corp's AVNS Position: Q4 2024 in Review

Associated Banc-Corp sold out of Avanos Medical (AVNS) in Q4 2024, closing a stake of 12,718 shares — an estimated $306K sold.

Associated Banc-Corp first reported a position in AVNS in Q4 2014 and held it in 40 quarters. The position peaked at $7.29M in Q1 2015. 258 funds tracked by Wall St. Rank hold AVNS as of Q4 2024.

  • Associated Banc-Corp reported no remaining Avanos Medical position as of Q4 2024 after selling out during the quarter.
  • Associated Banc-Corp sold 12,718 Avanos Medical shares in Q4 2024, an estimated $306K.
  • Associated Banc-Corp first reported a position in Avanos Medical in Q4 2014 and held it in 40 quarters.
  • Associated Banc-Corp's Avanos Medical position peaked at $7.29M in Q1 2015.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2024.

Based on Associated Banc-Corp's 13F filing for Q4 2024, filed 10 Feb 2025.